DiaMedica Therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is a significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases.

Biotechnology

DiaMedica Therapeutics

Rick Pauls

Beth Larson-DeBruzzi

David Wambeke

Scott Kellen, CPA (inactive)

Julie Vanorsdel Daves

Dominic R. Cundari

Kirsten Gruis

Scott Kellen

Scientific Advisory Team

Leadership Team

Finance and Administrative Team

Clinical Operations Team

��

Teams at DiaMedica Therapeutics

Scientific Advisory Team

Leadership Team

Finance and Administrative Team

Clinical Operations Team

��������

Teams at DiaMedica Therapeutics

Scientific Advisory Team

Leadership Team

Finance and Administrative Team

Clinical Operations Team

��